Skip to content

Test observation of human body test on the treatment of chloasma with Lutai Danshen Baishao Granules, a Chinese medicine compound health product

Test observation of human body test on the treatment of chloasma with Lutai Danshen Baishao Granules, a Chinese medicine compound health product

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054827
Enrollment
Unknown
Registered
2021-12-28
Start date
2021-12-27
Completion date
Unknown
Last updated
2022-12-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melasma

Interventions

Sponsors

Kangao Technology Group Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Females aged 18-65 years; 2. Stable chloasma, light brown to dark brown on the face, distinct plaques, usually symmetrically distributed, without inflammatory manifestations and scales; 3. No obvious symptoms; 4. Voluntarily signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Chloasma caused by disease; 2. Pregnant, pregnant or breastfeeding women; 3. Allergic constitution and those who are allergic to this health food; 4. Patients with severe diseases such as cardiovascular, cerebrovascular, liver, kidney and hematopoietic system, endocrine diseases, and mental illness; 5. An alcoholic (alcohol amount <15g, alcohol amount = drinking amount x alcohol concentration x 0.8) or smoker; 6. Those who have taken or applied externally freckle and whitening products within 4 weeks before the start of the food trial, or have had laser or fruit acid treatment, which will affect the judgment of the results.

Design outcomes

Primary

MeasureTime frame
Melasma Area and Severity Index;Heart rate, heart rhythm, blood pressure;

Secondary

MeasureTime frame
Dermatological Quality of Life Index Questionnaire;

Countries

China

Contacts

Public ContactWang Linyuan

Beijing University of Chinese Medicine

wanglinyuan110@vip.163.com+86 13381002202

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026